Life Science / Pharmaceuticals and Biotech

Life science businesses develop, produce, market and distribute pharmaceuticals, from the biotech stage to finished and clinically applicable products. Food industry businesses may also be engaged in activities characterised as life science.

Among the key characteristics of the life science industry are:

• the crucial importance of intellectual property rights, in particular patent rights, for the strategic options available
• the considerable research costs and consequent recurrent need for procurement of capital in situations where the future of the business is uncertain
• the extensive and complicated statutory requirements governing the industry, its activities and products, and ultimately the marketing and distribution of products
• the massive potential liability risks in case of errors during clinical tests, defects in marketed pharmaceuticals, etc.
• a tradition of cross-field cooperation and mutual licence agreements making competition law compliance an important issue.

In the life science field, legal advice at a highly qualified level requires special experience and in-depth knowledge of the industry. Our life science group, therefore, consists of persons with particular interest and experience in the pharmaceutical and biotech industry.

Our expertise

Kromann Reumert’s life science group combines expertise gathered from a number of our specialist groups.

Together they cover all legal aspects that are important to both newly formed and long established life science businesses.